MyFinsight
Home
Blog
About
Contact
Download
Download image
Investments
$14,927,165
Cash and cash
equivalents
$3,818,096
Prepaid expenses and
other current assets
$1,261,974
Total current assets
$20,007,235
Intangible assets, net
$383,334
Total assets
$20,390,569
Total liabilities and
shareholders' equity
$20,390,569
Total shareholders'
equity
$13,119,906
Total liabilities
$7,270,663
Accumulated deficit
-$70,970,447
Accumulated other
comprehensive loss
-$613
Additional paid in capital
$84,090,966
Total current
liabilities
$5,546,930
Due to officers -
long term
$1,723,733
Accrued expenses
$2,538,457
Accounts payable
$1,262,222
Accrued interest and
financing expense
$1,146,251
Due to officers -
short term
$600,000
Back
Back
Balance Sheet
source: myfinsight.com
Quoin Pharmaceuticals, Ltd. (QNRX)
Quoin Pharmaceuticals, Ltd. (QNRX)